Meeting NewsVideo

VIDEO: Neurotech implant shows positive safety profile

February 13, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at Byers Eye…
In the JournalsPerspective

Periodontal disease may be risk factor for AMD

February 13, 2020
Periodontal diseases are a possible additional risk factor for age-related macular degeneration; however, the link between the two remains unclear…
Meeting NewsVideo

VIDEO: Aerie to test Rho kinase inhibitor implant for glaucoma

February 13, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Casey C. Kopczynski, PhD, chief scientific officer and co-founder of Aerie…
Meeting News

NCX 470 shows positive IOP reduction in phase 2 trial

February 12, 2020
SAN FRANCISCO — NCX 470, Nicox’s novel second-generation nitric oxide-donating bimatoprost analog, showed superior IOP lowering compared…
Residency to Retirement Resource Center

Compound interest: A powerful ancillary revenue stream

February 12, 2020
With health care continuously in flux, physicians of all specialties have often wondered how to maintain their income and achieve financial goals…

SECO 20/20 partners with eight organizations at annual conference

February 12, 2020
SECO 20/20 has partnered with eight organizations to host co-located events during its 2020 annual conference where the latest research, innovations…
Meeting NewsVideo

VIDEO: Berdahl gives tips to entrepreneurship success

February 12, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, John P. Berdahl, MD, discusses how to bring a product from an idea to market success.
Meeting News

Eylea reduced risk for vision-threatening complications at 2 years

February 12, 2020
The 2-year results of the phase 3 PANORAMA trial evaluating intervention with aflibercept for patients with moderately severe to severe…
In the JournalsPerspective

Identifying SIRE may aid in early detection of exudation

February 12, 2020
Patients with OCT images that displayed a shallow, irregular retinal pigment epithelium elevation sign had a higher risk for nonexudative macular…
Meeting News

Diabetic retinopathy confers stroke risk in diabetes

February 12, 2020
Among patients with diabetes, those with diabetic retinopathy had elevated stroke risk compared with those who did not, according to new data from…
Meeting NewsVideo

VIDEO: Communication key when addressing presbyopia correction

February 12, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, John A. Hovanesian, MD, FACS, discusses methods of communicating with patients about presbyopia…
Meeting NewsVideo

VIDEO: One-second laser treatment could allow glaucoma specialists to treat more patients

February 11, 2020
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Daria Lemann-Blumenthal, LLB, EMBA, CEO of Belkin Laser, discusses the…
Meeting News

Preliminary data show intracameral implant reduces IOP up to 9 months

February 11, 2020
SAN FRANCISCO — An intracameral travoprost implant reduced IOP for up to 9 months in preliminary results from a phase 1 study, according to a…
Meeting NewsVideo

VIDEO: Treating glaucoma with medical therapy vs. SLT

February 11, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Christine L. Larsen, MD, discusses her presentation on the role of medical therapy as primary treatment…
In the JournalsPerspective

Higher doses of metformin associated with lower risk for AMD

February 11, 2020
A population-based, retrospective cohort study showed an association between metformin and a lower risk for age-related macular degeneration…
Meeting News

iDose lowers IOP, shows no significant adverse events in phase 2 trial

February 10, 2020
SAN FRANCISCO — The iDose, a titanium implant from Glaukos for continuous drug delivery, has shown positive phase 2 results and is currently in…

Roberts leaving Bausch to lead Lighthouse Guild

February 10, 2020
Calvin Roberts, MD, is stepping down as senior vice president and chief medical officer of eye care at Bausch Health Companies to take over as…

Positive results seen in fourth cohort of OpRegen phase 1/2a study

February 10, 2020
Based on positive early data available for the first five patients in a phase 1/2a clinical study of OpRegen, Lineage Cell Therapeutics announced it…
Blog

BLOG: What is outer retinal tubulation?

February 10, 2020
Last month we talked about the “new” nomenclature for the bands of the outer retina as identified on OCT – and how we should all…
Meeting NewsVideo

VIDEO: Aerie official shares phase 4 trial data on Rhopressa use

February 10, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, discusses recent data…